At Makewell and ECG Healthcare, we understand that hearing about cases of meningitis can feel worrying – especially for parents and those working in healthcare or education.
The good news is that meningococcal disease remains rare in the UK, and we have effective vaccines and clear guidance to help keep people safe. This Q&A is designed to give you clear, calm and practical information so you feel informed and confident about what to do.
1. How common is meningitis, and why is it in the news?
Meningitis is thankfully rare in the UK, but it can occur in clusters or local outbreaks and is closely monitored by public health teams, who act quickly to reduce further spread.
While most people will never be affected, it can feel worrying because it is a serious disease and, in rare cases, life-threatening. The current outbreak doesn’t mean the risk to most people is high, but it is a good time to be informed.
The Chief Executive of the charity Meningitis Now, Tom Nutt advises:
“Despite what has happened in Kent, we would like to reiterate that meningitis is a relatively rare disease. In the long-run, the good news is that the NHS vaccination programme has been very successful in bringing down the number of cases of meningitis in the UK.”
2. What is Meningitis B and is it the same as Meningitis ACWY?
Meningococcal disease is caused by different groups (or “strains”) of bacteria.
Meningitis B is the most common cause of meningococcal disease in young children in the UK.
Meningitis ACWY protects against four other strains (A, C, W and Y), which are more often seen in older children, teenagers and young adults. Some adults will also need Meningitis ACWY vaccination for travel purposes.
The vaccines are different, so being vaccinated against one type does not protect you against all types.
3. How serious is Meningitis B infection?
Although rare, Meningitis B infection can be very serious. It can lead to meningitis (an infection of the lining of the brain) and/or sepsis (blood poisoning), both of which can develop quickly. Early recognition and treatment are key, and most people recover well when treated promptly.
4. Who is most at risk?
It’s important to remember that the overall risk remains low, but those who may be at higher risk include:
- Babies and young children
- Teenagers and young adults
- People with certain medical conditions affecting the immune system
- Individuals in close-contact settings (such as student accommodation)
In the UK, the Meningitis B vaccine is part of the routine childhood immunisation programme, so younger children will usually have already been offered protection. However, many older teenagers and young adults
– who can also be at increased risk – will not have received this vaccine through the NHS.
5. What are the benefits of vaccination?
Vaccination is the most effective way to protect against Meningitis B. It helps the immune system recognise and fight the bacteria quickly if exposed. The Meningitis B vaccine has significantly reduced cases in vaccinated groups in the UK and is a key part of keeping children safe.
Yes, the Men B vaccine has been extensively tested and is considered safe.
Like many vaccines, it can cause mild side effects such as:
- Fever (particularly in babies)
- Redness or swelling at the injection site
- Irritability or tiredness
These side effects are usually short-lived and a sign that the immune system is responding.
The vaccine provides good protection, particularly in the years following vaccination. While protection may reduce over time, it still plays an important role in reducing both the risk and severity of illness.
7. Should I consider vaccination for myself or my child?
The Men B vaccine has been routinely offered to babies in the UK as part of the NHS childhood immunisation programme since 2016. If your child has missed any routine vaccinations, your GP practice or Health Visitor can help arrange a catch-up schedule.
For older children, teenagers and adults, the Men B vaccine is not routinely offered on the NHS. However, some people choose to have it privately, particularly if they want additional protection – for example, before starting university or entering shared living environments.
Private vaccinations are available from a local pharmacy or a private clinic such as Makewell with a 2-dose course costing around £110 for each dose. Stocks are currently affected by an increase in demand, but most services are actively seeking to obtain additional vaccines to meet clients’ needs.
8. What symptoms should I look out for?
Early symptoms can be similar to common viral illnesses and may include:
- Fever
- Muscle Aches
- Headache
- Feeling unsually tired
- Vomiting
In babies and young children, signs may also include poor feeding, irritability, or a high-pitched cry. Symptoms can develop quickly, so it’s important to monitor closely and seek medical help if you are concerned.
9. When should I seek urgent medical advice?
Seek urgent medical attention if you notice any of the following:
- A rash that does not fade when pressed
- Severe headache or neck stiffness
- Sensitivity to light
- Confusion or drowsiness
- Cold hands and feet, limb pain, or pale/mottled skin
- Seizures
- Difficulty breathing
As always, if you are concerned, trust your instincts – particularly with young children. It is always better to seek advice early. Contact 111 for advice or call 999 if the person you are concerned about is drowsy, has a decreased level of consciousness or is having difficulty breathing.
10. What is a “superspreader event” and should I be worried?
You may have heard the term “superspreader event” in the news or on social media. This refers to a situation where one person passes an infection to a larger number of people than usual, often in close-contact settings. With meningococcal bacteria, spread requires close and prolonged contact (such as living in the same household or sharing utensils). It is not spread as easily as common colds or flu.
While the term can sound alarming, these events are uncommon. Public health teams act quickly to identify contacts and provide advice or preventative treatment where needed. For most people, the risk remains low. Staying aware of symptoms and keeping vaccinations up to date are the most effective ways to protect yourself and others.
11. Should I wear a face mask?
Routine mask-wearing is not generally recommended for the public. This is because the bacteria do not spread easily through casual contact or brief exposure in the same way as respiratory viruses like COVID-19.
The most important ways to reduce risk are:
- Avoiding sharing drinks, utensils, or toothbrushes
- Maintaining good general hygiene
- Being aware of symptoms
- Taking up vaccination where appropriate
Masks may still be used in healthcare settings or if advised during a specific public health situation, but for most people going about daily life, they are not necessary for protection against Meningitis B.
Final reassurance
While meningitis can be serious, it remains uncommon. Vaccination, awareness of symptoms, and knowing when to seek help are the most effective ways to stay safe.
If you have any concerns or would like to discuss vaccination, our team is here to help.
